Ticker

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that effective April 21, 2026 its corporate name will change from “Algernon Health Inc.” to “Grey Matters Health Inc.” and the Company will consolidate its Class A common shares (the “Common Shares”) on a ten (10) to…

Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) told investors that its previously announced rebranding to Grey Matters Health will take effect April 21,...

Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) said on Wednesday it plans to change its corporate name to Grey Matters Health Inc, reflecting a strategic shift toward brain health and the growing Alzheimer's disease diagnostics market. The company has reserved the new ticker symbol ‘GREY' with the Canadian Securities Exchange and said updated symbols for its US and Frankfurt listings will be announced later.

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from “Algernon Health Inc.” to “Grey Matters Health Inc.” (the “Name Change”). The Company has reserved the new name and new symbol “GREY” with the Canadian Securities…

Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) earlier this week outlined plans to expand into nuclear medicine with the launch of a network of specialized brain imaging clinics across the United States, beginning with its first site in Florida. In an interview with Proactive, CEO Christopher Moreau said the company is targeting a significant gap in diagnostic capacity for Alzheimer's disease, particularly as new…